Home » Topics » Regulatory

Regulatory
RSS

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Nasonex Nasal Spray cleared for marketing in U.S.

Oct. 6, 1997

FDA clears Serevent Diskus

Oct. 3, 1997

Preclinical pharmacokinetic/efficacy data on MiKasome presented at ICAAC

Oct. 1, 1997

First combination anti-HIV drug approved in U.S.

Sep. 30, 1997

Pentoxifylline demonstrates gastroprotective effects in patient study

Sep. 30, 1997

Celgene seeks FDA approval for clinical trials with thalidomide for autoimmune disorders

Sep. 29, 1997

New indication for lamotrigine tested in patients: ADHD

Sep. 26, 1997

Metrifonate efficacy in AD demonstrated in clinical trial

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...